700 completed. 700 Phase 1, 122 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 700 | Completed 700 |
| Phase 2 | 122 | Completed 122 |
Follow Hypersensitivity: new trials by email Literature Review of Hypersensitivity trials Research Report on Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Food Effect Study of VC005 Tablets in Healthy Adult Subjects. VC005 Tablets - Atopic Dermatitis | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 31 | 2026-04-23 | 2026-06-08 |
| A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects SHR-1819 Injection - Atopic Dermatitis | Phase 1 | Completed | Guangdong Hengrui Pharmaceutical Co., Ltd | 160 | 2026-03-07 | 2026-08-24 |
| A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection GS101 injection, U.S. commercial Dupixent®, CN commercial Dupixent® - Atopic Dermatitis (AD) | Phase 1 | Completed | Jiangsu Genscend Biopharmaceutical Co., Ltd | 294 | 2026-03-05 | 2026-10-15 |
| A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma Budesonide/formoterol fumarate Aerosphere, Budesonide/formoterol fumarate pMDI - Asthma | Phase 1 | Completed | AstraZeneca | 16 | 2026-03-05 | 2026-07-15 |
| Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS) JTE-162 - Cryopyrin-associated Periodic Syndromes (CAPS) | Phase 1 | Completed | Akros Pharma Inc. | 5 | 2026-02-02 | 2026-10-09 |
| Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers AJU-R713, R713R - Bronchial Asthma, Perennial Allergic Rhinitis | Phase 1 | Completed | AJU Pharm Co., Ltd. | 62 | 2025-12-12 | 2026-09-18 |
| Phase I Study of PollenVax in Patients With Mugwort Pollen-Induced Allergic Rhinitis PollenVax, Placebo - Rhinitis Allergic | Phase 1 | Completed | Kazakh National Agrarian University | 30 | 2025-11-22 | 2026-06-29 |
| Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis VC005 - Atopic Dermatitis (AD) | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 11 | 2025-11-11 | 2026-04-13 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes HRS-3095 Tablet, HRS-3095 Placebo Tablet - Chronic Spontaneous Urticaria | Phase 1 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 82 | 2025-11-10 | 2026-06-12 |
| A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults. PF-08049820, Rabeprazole - Healthy Adults | Phase 1 | Completed | Pfizer | 18 | 2025-11-03 | 2026-09-09 |
| PK/PD Study of IN-001 Sublingual Spray in Healthy Adults Epinephrine Auto-Injector 0.3 mg/0.3 mL, Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle, IN-001 9.06 mg Sublingual Spray - Food Allergy, Anaphylaxis | Phase 1 | Completed | Insignis Therapeutics, Inc. | 32 | 2025-10-24 | 2026-05-05 |
| Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis ATTO-3712, Placebo - Normal Volunteers, Atopic Dermatitis (AD) | Phase 1 | Completed | Attovia Therapeutics Inc | 48 | 2025-10-22 | 2026-09-11 |
| A Clinical Study to Evaluate SM17 in Healthy Participants SM17, SM17 placebo - Atopic Dermatitis, Asthma | Phase 1 | Completed | SinoMab BioScience Ltd | 30 | 2025-10-14 | 2026-04-06 |
| A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants PF-08049820, Midazolam, Dabigatran Etexilate - Atopic Dermatitis | Phase 1 | Completed | Pfizer | 16 | 2025-10-03 | 2026-09-09 |
| Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis ENV-294 Capsule - Atopic Dermatitis (AD) | Phase 1 | Completed | Enveda Therapeutics | 9 | 2025-09-10 | 2026-04-01 |
| A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults PF-08049820 MR1, PF-08049820 MR2, PF-08049820 IR - Atopic Dermatitis | Phase 1 | Completed | Pfizer | 12 | 2025-09-05 | 2025-11-17 |
| Comparing the Availability of AQ280 in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation AQ280 Capsule, AQ280 Tablet for Oral Suspension, Placebo Capsule - Eosinophilic Esophagitis | Phase 1 | Completed | AQILION AB | 9 | 2025-06-13 | 2026-06-01 |
| A Study of Inhaled AZD8630 in Adolescents With Asthma AZD8630, Dry powder inhaler - Asthma | Phase 1 | Completed | AstraZeneca | 10 | 2025-06-11 | 2025-10-14 |
| The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers [14C]VC005 - Atopic Dermatitis | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 6 | 2025-05-26 | 2025-07-11 |
| A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Healthy and Asthmatic Participants Placebo, IBI3002 - Asthma | Phase 1 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 44 | 2025-05-14 | 2026-06-09 |
Showing 20 of 700. Sign in to see all of them.
Asthma (312) · Dermatitis, Atopic (154) · Rhinitis, Allergic (61) · Pulmonary Disease, Chronic Obstructive (39) · Rhinitis, Allergic, Seasonal (31) · Peanut Hypersensitivity (26) · Food Hypersensitivity (25) · Angioedemas, Hereditary (18) · Eczema (17) · Hypersensitivity, Immediate (15) · Rhinitis, Allergic, Perennial (15) · Anaphylaxis (12) · Urticaria (12) · Chronic Urticaria (11)
Immune System Diseases (693) · Hypersensitivity, Immediate (633) · Respiratory Tract Diseases (398) · Respiratory Hypersensitivity (393) · Lung Diseases (314) · Bronchial Diseases (313) · Lung Diseases, Obstructive (312) · Skin and Connective Tissue Diseases (206) · Skin Diseases (200) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (181) · Genetic Diseases, Inborn (179) · Skin Diseases, Eczematous (158) · Skin Diseases, Genetic (157) · Dermatitis (152)
Budesonide (24) · Fluticasone (17) · Omalizumab (12) · montelukast (12) · Charcoal (11) · Formoterol Fumarate (8) · Sodium Chloride (8) · Albuterol (7) · Epinephrine (7) · Budesonide, Formoterol Fumarate Drug Combination (6) · Fluticasone-Salmeterol Drug Combination (6) · Saline Solution (6) · Salmeterol Xinafoate (6) · fluticasone furoate (6) · Beclomethasone (5)
GlaxoSmithKline (72) · AstraZeneca (37) · Pfizer (20) · National Institute of Allergy and Infectious Diseases (NIAID) (15) · Merck Sharp & Dohme LLC (14) · LEO Pharma (13) · Orion Corporation, Orion Pharma (13) · University of North Carolina, Chapel Hill (11) · Chiesi Farmaceutici S.p.A. (8) · MedImmune LLC (8) · Novartis Pharmaceuticals (8) · Amgen (7) · Boehringer Ingelheim (7) · Regeneron Pharmaceuticals (7) · ALK-Abelló A/S (6)
United States (257) · United Kingdom (104) · Germany (76) · China (51) · Canada (43) · Australia (42) · South Korea (18) · Netherlands (17) · New Zealand (14) · Belgium (13) · Finland (12) · Japan (11) · Spain (11) · Taiwan (9) · Sweden (8)
Robert Wood, MD (9) · Cecil Charles, PhD (3) · David B Peden, MD, MS (3) · Edwin Kim, MD (3)
PMID 24184147, PMID 19001265, PMID 22464647, PMID 19680119, PMID 22726593, PMID 23374268, PMID 24035151, PMID 29136286, PMID 32414772, PMID 32907575, PMID 38010254, PMID 40185989, PMID 10831441, PMID 11069570, PMID 11163535, PMID 11297958, PMID 11468003, PMID 11728816, PMID 15379842, PMID 1538192, PMID 15577929, PMID 16375711, PMID 16553814, PMID 17083353, PMID 17346444, PMID 17717202, PMID 18244953, PMID 18951617, PMID 19226304, PMID 19446146, PMID 19647862, PMID 19717725, PMID 19821718, PMID 19944580, PMID 20216101, PMID 20706632, PMID 20921983, PMID 20976161, PMID 21057005, PMID 21414048, PMID 21639872, PMID 21642470, PMID 21725898, PMID 21729182, PMID 22042247, PMID 22393898, PMID 22544892, PMID 22616628, PMID 22621776, PMID 22955319
2014 (11), 2016 (8), 2018 (8), 2015 (6), 2009 (4), 2019 (4), U19AI095261 (3), 2017 (2), 2023 (2), P01AT002620 (2), P01HL158507 (2), P01AT002647 (1), P50AT002782 (1), P50DC007667 (1), R01AT004435 (1)